Stocks analysis

Analysis for AXON

  • 📈 Growth — 30/30
  • 💰 Profitability — 16/20
  • 🏦 Financial Health — 18/20
  • 💵 Valuation — 15/20
  • ⚠️ Risk — 4/10
Overall Score: 85/100

Summary:


📈 Growth & Financial Trajectory

Eight quarters show robust expansion from Q1 2024 to Q1 2026. Revenues rise from about $459.9M to $807.3M, a growth of roughly 75%. Net Income increases from about $133.4M to $169.3M over the period, despite quarterly fluctuations. Overall, the trend is positive with scale benefits evident by the end of Q1 2026.

💰 Margins & Cash Flow

Average Gross Margin around 61% with periods of higher margin when cost of revenue stays lean. Operating margins hover in the single-digit area, but profitability remains positive across most quarters, aided by substantial gross profits. Note cash flow dynamics: Net Cash Flow From Operating Activities varied and weakened to about -$31.5M in the latest quarter, while heavy investing pushes total Net Cash Flow to about -$742.2M in Q1 2026.

🛡️ Balance Sheet & Liquidity

Healthy balance sheet: Cash around $736.97M, Long-term Debt about $1.73B, and Equity near $3.53B. With current assets ~ $2.74B and current liabilities ~ $1.21B, the Current Ratio is around 2.3, supporting liquidity despite ongoing investing.

⚠️ Key Drivers & Risks

  • Drivers: AI-enabled analytics/evidence management; broad adoption of body-worn cameras and cloud-based solutions.
  • Risks: Government-budget exposure and cyclicality; competitive and regulatory sensitivities affecting valuation.